Other intriguing research showed that BC patients had greater levels of serum exosomal-annexin A2 (exo-AnxA2) than females without cancer, particularly for triple-negative BC (TNBC) as opposed to luminal and HER2-positive BC. Here, ANXA2 is linked to breast cancer.